论文部分内容阅读
肝细胞癌(HCC)是最常见的恶性肿瘤之一,由于快速浸润性生长及合并肝硬化因此其预后不良。局部介入疗法的出现,是治疗不能切除HCC的重大突破,局部治疗HCC有许多疗法,包括经肝动脉的化疗栓塞(TACE)疗法,经皮酒精注射(PEI)疗法、射频消融(RFA)疗法、微波凝固疗法(MCT)、激光疗法(LITT)、免疫疗法、基因疗法、血管生成抑制疗法、中医疗法等。肝动脉的化疗栓塞(TACE)是最常用的疗法,每一种疗法都有其优势和不足,而TACE和其他的局部疗法联合能够克服一些不足,提高患者的生存率。
Hepatocellular carcinoma (HCC) is one of the most common malignancies and its prognosis is poor due to rapid infiltration of growth and cirrhosis. The emergence of local intervention is a major breakthrough in the treatment of unresectable HCC. There are many therapies for local treatment of HCC, including transcatheter arterial chemoembolization (TACE), percutaneous ethanol injection (PEI), radiofrequency ablation (RFA) Microwave coagulation therapy (MCT), laser therapy (LITT), immunotherapy, gene therapy, angiogenesis inhibition therapy, Chinese medicine therapy. Transcatheter arterial chemoembolization (TACE) is the most commonly used therapy, each therapy has its advantages and disadvantages, and TACE and other local therapies can overcome some deficiencies and improve patient survival.